TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer

British Journal of Cancer

Volumn 109, Issue 6, 2013, Pages 1685-1692

  Liu, T ^a   Gao, H ^a   Chen, X ^a   Lou, G ^a   Gu, L ^a   Yang, M ^a   Xia, B ^a   Yin, H ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Mudanjiang Tumor Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; METASTASIS; OVARY CARCINOMA; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS REGULATORY PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84884586671     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.501     Document Type: Article

References (33)

1. Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B, Kohn EC (2010) Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer. Cancer 116: 3276-3284.
2. Benedet JL, Bender H, Jones 3rd H, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70: 209-262.
3. Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, Sonoda Y, Levine DA, Hensley M, Barakat RR (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103: 559-564.
4. Chi DS, Franklin CC, Levine DA, Akselrod F, Sabbatini P, Jarnagin WR (2004) Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: A change in surgical approach. Gynecol Oncol 94: 650-654.
5. Dong QZ, Zhao Y, Liu Y, Wang Y, Zhang PX, Jiang GY, Dong XJ, Cui QZ, Wang EH (2010) Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung cancer. Cancer Sci 101: 1562-1569.
6. Eisenkop SM, Friedman RL, Wang HJ (1998) Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study. Gynecol Oncol 69: 103-108.
7. Fleming , Ronnett B, Seidman J, Zaino RJ, Rubin SC (2009) Epithelial Ovarian Cancer. In Principles and Practice of Gynecologic Oncology, Barakat RR, Markman M, Randall ME (eds). pp 763-835. Lippincott Willians & Wilkins: Philadelphia, PA, USA.
8. Freundt EC, Bidere N, Lenardo MJ (2008) A different TIPE of immune homeostasis. Cell 133: 401-402.
9. Hadisaputri YE, Miyazaki T, Suzuki S, Yokobori T, Kobayashi T, Tanaka N, Inose T, Sohda M, Kuwano H (2012) TNFAIP8 overexpression: Clinical relevance to esophageal squamous cell carcinoma. Ann Surg Oncol 19(Suppl 3): S589-S596.
10. Horrevoets AJ, Fontijn RD, van Zonneveld AJ, de Vries CJ, ten Cate JW, Pannekoek H (1999) Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes. Blood 93: 3418-3431.
11. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
12. Kumar D, Gokhale P, Broustas C, Chakravarty D, Ahmad I, Kasid U (2004) Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene 23: 612-616.
13. Kumar D, Whiteside TL, Kasid U (2000) Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein. J Biol Chem 275: 2973-2978.
14. Laliberté B, Wilson AM, Nafisi H, Mao H, Zhou YY, Daigle M, Albert PR (2010) TNFAIP8: A new effector for Galpha(i) coupling to reduce cell death and induce cell transformation. J Cell Physiol 225: 865-874.
15. Liu K, Qin CK, Wang ZY, Liu SX, Cui XP, Zhang DY (2012) Expression of tumor necrosis factor-alpha-induced protein 8 in pancreas tissues and its correlation with epithelial growth factor receptor levels. Asian Pac J Cancer Prev 13: 847-850.
16. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
17. McSane LM, Altman DG, Sauerbrei W, Sauerbrei SE, Gion M, Clark GM (2005) REporting recommendations for tumour MARKer prognostic studie (REMARK). Br J Cancer 93: 387-391.
18. Miao Z, Zhao T, Wang Z, Xu Y, Song Y, Wu J, Xu H (2012) SCC-S2 is overexpressed in colon cancers and regulates cell proliferation. Tumour Biol 33: 2099-2106.
19. Morgan RJ, Alvarez RD, Armstrong DK, Boston B, Burger R, Chen LM, Copeland L, Crispens MA, Fowler J, Gaffney DK, Gershenson D, Greer BE, Grigsby PW, Havrilesky LJ, Johnston C, Lancaster JM, Lele S, Markman M, Matulonis UA, O'Malley DM, Ozols RF, Penson RT, Remmenga SW, Sabbatini P, Schink J, Teng N (2009) Ovarian cancer including Fallopian tube cancer and Primary peritoneal cancer. NCCN clinical practice guidelines in oncology.
20. Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R. Gynecologic Oncology Group (2003) Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study. J Clin Oncol 21: 3194-3200.
21. Park HJ, Nam EJ, Rha SY, Kim S, Kim SW, Kim JW, Kim YT (2012) A new prognostic index model using meta-analysis in early-stage epithelial. Gynecol Oncol 126: 357-363.
22. Patel S, Wang FH, Whiteside TL, Kasid U (1997) Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: Implications in metastasis and/or radiation response. Oral Oncol 33: 197-203.
23. Richardson GS, Scully RE, Nikrui N, Nelson Jr JH (1985) Common epithelial cancer of the ovary (2). N Engl J Med 312: 415-424.
24. Shi TY, Cheng X, Yu KD, Sun MH, Shao ZM, Wang MY, Zhu ML, He J, Li QX, Chen XJ, Zhou XY, Wu X, Wei Q (2013) Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes. Carcinogenesis 34: 770-778.
25. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
26. Soumaoro LT, Uetake H, Higuchi T, Takagi Y, Enomoto M, Sugihara K (2004) Cyclooxygenase-2 expression: A significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 10: 8465-8471.
27. Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J, Kong L, Xu L, Hilliard B, Hu S, Shen H, Yang X, Chen YH (2008) TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 133: 415-426.
28. Tavassoeli FA, Devilee P (2003) WHO Classification of Tumours, Pathology and Genetics: Tumours of the Breast and Female Genital Organs. IARC: Lyon, France.
29. You Z, Ouyang H, Lopatin D, Polver PJ, Wang CY (2001) Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem 276: 26398-26404.
30. Zhang C, Chakravarty D, Sakabe I, Mewani RR, Boudreau HE, Kumar D, Ahmad I, Kasid UN (2006) Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther 13: 947-955.
31. Zhang C, Kallakury BV, Ross JS, Mewani RR, Sheehan CE, Sakabe I, Luta G, Kumar D, Yadavalli S, Starr J, Sreenath TL, Srivastava S, Pollard HB, Eidelman O, Srivastava M, Kasid UN (2013) The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence. Int J Cancer 133: 31-42.
32. Zhang HG, Hyde K, Page GP, Brand JP, Zhou J, Yu S, Allison DB, Hsu HC, Mountz JD (2004) Novel tumor necrosis factor alpha-regulated genes in rheumatoid arthritis. Arthritis Rheum 50: 420-431.
33. Zhang Y, Wang MY, He J, Wang JC, Yang YJ, Jin L, Chen ZY, Ma XJ, Sun MH, Xia KQ, Hong XN, Wei QY, Zhou XY (2012) Tumor necrosis factor-a induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: A case-control study. PLoS One 7: E37846.